Hinge Health, Inc. carries a market capitalization of 9.04B, placing it among publicly traded companies globally. Its enterprise value stands at 6.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.04B |
| Enterprise Value | 6.27B |
Hinge Health, Inc. currently has 80.20M shares outstanding.
| Shares Outstanding | 80.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Hinge Health, Inc. trades at a trailing price-to-earnings ratio of 60.11. The price-to-sales ratio is 9.11, and the price-to-book ratio stands at 19.33.
| PE Ratio | 60.11 |
| PS Ratio | 9.11 |
| PB Ratio | 19.33 |
| P/TBV Ratio | 23.93 |
| P/FCF Ratio | 23.44 |
| P/OCF Ratio | 22.55 |
On an enterprise value basis, Hinge Health, Inc. trades at an EV/EBITDA multiple of 63.76 and an EV/FCF ratio of 21.52. The EV/Sales ratio of 8.71 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 66.97 provides insight into valuation relative to core operating earnings.
| EV / Sales | 8.71 |
| EV / EBITDA | 63.76 |
| EV / EBIT | 66.97 |
| EV / FCF | 21.52 |
Hinge Health, Inc. maintains a current ratio of 1.34, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.34 |
| Quick Ratio | 1.07 |
| Debt / Equity | 1.71 |
| Debt / EBITDA | 0.06 |
| Interest Coverage | N/A |
Hinge Health, Inc. posts a return on equity of 42.10 and a return on invested capital of 24.71.
| Return on Equity (ROE) | 42.10 |
| Return on Assets (ROA) | 14.34 |
| Return on Invested Capital (ROIC) | 24.71 |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.26 |
Over the trailing twelve months, Hinge Health, Inc. has paid 1.88M in income taxes, reflecting an effective tax rate of 1.70.
| Income Tax | 1.88M |
| Effective Tax Rate | 1.70 |
Hinge Health, Inc.'s stock has gained approximately 125.17089% over the past 52 weeks. The 50-day moving average sits at 94.09, while the 200-day moving average is 64.44.
| Beta (5Y) | N/A |
| 52-Week Price Change | 125.17089% |
| 50-Day Moving Average | 94.09 |
| 200-Day Moving Average | 64.44 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Hinge Health, Inc. generated 720.06M in revenue and converted that into 109.07M in net income, yielding earnings per share of 1.33. EBITDA reached 98.39M, while operating income came in at 93.67M.
| Revenue | 720.06M |
| Gross Profit | 608.41M |
| Operating Income | 93.67M |
| Pretax Income | 110.95M |
| Net Income | 109.07M |
| EBITDA | 98.39M |
| EBIT | 93.67M |
| Earnings Per Share (EPS) | 1.33 |
Hinge Health, Inc. holds 389.39M in cash and equivalents against 5.89M in total debt, resulting in a net debt position of -286.22M. Total book value stands at 344.33M, with working capital of 161.91M providing operational flexibility.
| Cash & Cash Equivalents | 389.39M |
| Total Debt | 5.89M |
| Net Debt | -286.22M |
| Equity (Book Value) | 344.33M |
| Book Value Per Share | 4.29 |
| Working Capital | 161.91M |
Hinge Health, Inc. produced 290.79M in operating cash flow over the past twelve months. After subtracting -666,000.00 in capital expenditures, free cash flow totaled 290.12M - equivalent to 3.67 per share.
| Operating Cash Flow | 290.79M |
| Capital Expenditures | -666,000.00 |
| Free Cash Flow | 290.12M |
| FCF Per Share | 3.67 |
Hinge Health, Inc. operates with a gross margin of 84.49, reflecting its pricing power and cost economics. The operating margin of 13.01 and net profit margin of 15.15 provide insight into operational efficiency.
| Gross Margin | 84.49 |
| Operating Margin | 13.01 |
| Pretax Margin | 15.41 |
| Profit Margin | 15.15 |
| EBITDA Margin | 13.66 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 3.34 |
| FCF Yield | 4.27 |
Hinge Health, Inc. posts an Altman Z-Score of 8.09, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.09 |